Spectral Ai, Inc. (MDAIW) Stock Price & Analysis
Spectral Ai, Inc. (MDAIW) fell 0.97% to USD 0.51 as of July 26, 2026 at 12:24 UTC, according to Nexqual real-time market data.
MDAIW last closed at USD 0.52; the session ranged USD 0.51–0.55 on volume of 9,329 shares. Market capitalization is —, with a 52-week range of USD 0.51–0.55 (NCM). Source: Nexqual, July 26, 2026 at 12:24 UTC.
Key Statistics (as of July 26, 2026 at 12:24 UTC)
| Price | USD 0.51 |
|---|---|
| Change | ▼ 0.97% (down) |
| Previous Close | USD 0.52 |
| Open | USD 0.83 |
| Day Range | USD 0.51 – 0.55 |
| 52-Week Range | USD 0.51 – 0.55 |
| Volume | 9,329 shares |
| Market Cap | — |
| Exchange | NCM |
Analyst Ratings (MDAIW)
Wall Street analysts rate MDAIW "None", per Nexqual as of July 26, 2026 at 12:24 UTC.
| Consensus Rating | None |
|---|
Earnings (MDAIW)
| Revenue Estimate | $4.79M |
|---|
Source: Nexqual, July 26, 2026 at 12:24 UTC.
Financials & Fundamentals (MDAIW)
| Total Revenue | $16.93M |
|---|---|
| Revenue Growth (YoY) | -40.50% |
| Gross Margin | +45.97% |
| Operating Margin | -49.39% |
| Profit Margin | -81.96% |
| Current Ratio | 0.75 |
| Total Cash | $11.65M |
| Total Debt | $9.94M |
| Free Cash Flow | $-697,625 |
Source: Nexqual, July 26, 2026 at 12:24 UTC.
Financial Health Score (MDAIW)
Nexqual rates Spectral Ai, Inc.'s overall financial health "Weak" across five dimensions, as of July 26, 2026 at 12:24 UTC.
| Growth | Critical — Revenue -34% YoY (annual), sharp decline |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Mixed — $12M cash vs $10M debt, net cash position |
| Cash Flow | Weak — FCF negative: -$698K, burning cash |
| Efficiency | Mixed — No data |
Ownership (MDAIW)
| Float | 27.56M |
|---|
Source: Nexqual, July 26, 2026 at 12:24 UTC.
Leadership (MDAIW)
Spectral Ai, Inc. is led by Vincent Stanley Capone (age 58), CEO & Corporate Secretary, per Nexqual as of July 26, 2026 at 12:24 UTC.
| CEO & Corporate Secretary | Vincent Stanley Capone (age 58) |
|---|---|
| Founder & Chairman | John Michael DiMaio (age 69) |
| Chief Operating Officer | Stanley Micek (age 63) |
| Chief Financial Officer | David McGuire (age 46) |
Major Backers & Investors (MDAIW)
Notable institutional backers of Spectral Ai, Inc. include Aristeia Capital, LLC, LMR Partners LLP, Clear Street Group Inc., according to Nexqual as of July 26, 2026 at 12:24 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Aristeia Capital, LLC | 3.17% |
| LMR Partners LLP | 2.71% |
| Clear Street Group Inc. | 2.51% |
| Goldman Sachs | 1.09% |
| Toronto Dominion Bank | 1.04% |
| Oasis Management Co Ltd. | 0.88% |
| Moore Capital Management, LP | 0.88% |
| Q Global Advisors, LLC | 0.88% |
Source: Nexqual, July 26, 2026 at 12:24 UTC.
From Spectral Ai, Inc.'s Latest SEC 10-K Filing (filed 2026-03-25)
Key Strengths & Strategy (as disclosed to the SEC)
- In addition to our validation study, we have conducted three large clinical studies with multiple sites across the United States, enrolling more than 400 patients, including both adult and pediatric burn patients.    2   Our proprietary and clinically validated database for burns is comprised of over 340 billion pixels of image data.
- Our DeepView System uses proprietary AI algorithms to distinguish between fully damaged, partially damaged and healthy human tissue characters invisible to the naked eye, at the initial time point of wound presentation.
- In 2026, we hope that our full DeepView System may achieve Class II medical device designation with the United States Food and Drug Administration (FDA) via the De Novo application the Company submitted in June of 2025.
- Our DeepView System's proprietary optics can extract millions of pixels of data or AI model features from each group of raw images.
Partnerships
- On September 27, 2023, the Company executed a new contract with BARDA, providing the Company with additional funding of up to $150.0 million, including an initial award of approximately $54.9 million to support the clinical validation and application for FDA De Novo status of our DeepView AI-Burn software.
- In April 2023, we were awarded a $4.0 million grant from the Medical Technology Enterprise Consortium ("MTEC"), a 501I(3) biomedical technology consortium working in partnership with the Department of Defense, to develop our DeepView SnapShot M device in a Phase III feasibility and commercialization study.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| MDAI | Spectral AI, Inc. | USD 1.64 | ▼ 1.8% |
| AISPW | Airship AI Holdings, Inc. | USD 0.51 | ▼ 7.27% |
| BFRGW | Bullfrog AI Holdings, Inc. Warr | USD 0.12 | ▲ 0% |
| MNTSW | Momentus Inc. | USD 0.01 | ▼ 30.23% |
| OPTXW | Syntec Optics Holdings, Inc. | USD 1.1 | ▼ 10.93% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 26, 2026 at 12:24 UTC. This page is informational and not investment advice.